Chargement en cours...
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea
Carcinoid syndrome (CS), characterized by diarrhea and flushing, is present in 20% of patients with neuroendocrine tumors at diagnosis and becomes more frequent with progression. The diarrhea of CS is caused mainly by tumoral secretion of serotonin. It may not be fully controlled by somatostatin ana...
Enregistré dans:
| Publié dans: | Future Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Future Medicine Ltd
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734517/ https://ncbi.nlm.nih.gov/pubmed/29350062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2017-0340 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|